16.03

1.60% -0.26

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $16.03, with a volume of 363.21K. It is down -1.60% in the last 24 hours and down -1.84% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Previous Close:

$16.29

Open:

$16.32

24h Volume:

363.21K

Relative Volume:

0.71

Market Cap:

$462.38M

Revenue:

$322.67M

Net Income/Loss:

$-61.63M

P/E Ratio:

-8.1561

EPS:

-1.9654

Net Cash Flow:

$-124.21M

1W Performance:

-0.62%

1M Performance:

-1.84%

6M Performance:

-32.13%

1Y Performance:

-15.19%

1-Day Range:

$15.81

$16.48

1-Week Range:

$15.81

$16.52

52-Week Range:

$13.46

$31.04

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1111)

Industry

Diagnostics & Research (52)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,315

Twitter

@FulgentGenetics

Next Earnings Date

2026-05-01

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	16.03	459.78M	322.67M	-61.63M	-124.21M	-1.9654
TMO Thermo Fisher Scientific Inc	466.70	194.94B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	178.57	137.69B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	560.93	45.19B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	114.42	34.50B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	311.20	32.91B	3.17B	642.63M	516.49M	10.77

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-05-25	Upgrade	UBS	Neutral → Buy
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

01:44 AM

Fulgent Genetics (FLGT) to Release Earnings on Friday - MarketBeat

01:44 AM

Apr 23, 2026

Fulgent Genetics rises on earnings, revenue beat - MSN

Apr 23, 2026

Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting - BioSpace

Apr 23, 2026

Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Analysts - MarketBeat

Apr 23, 2026

Apr 22, 2026

Fulgent Genetics to present nano-encapsulated anti-tumor drug FID-007 efficacy at ASCO meeting - Traders Union

Apr 22, 2026

Head and neck cancer study from Fulgent gets ASCO oral slot - Stock Titan

Apr 22, 2026

Apr 18, 2026

Fulgent Genetics (FLGT) Stock Pre Market (Momentum Building) 2026-04-18Top Picks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 18, 2026

Apr 17, 2026

Fulgent Genetics Under Investigation for Securities Law Violations - Intellectia AI

Apr 17, 2026

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - lincolnjournal.com

Apr 17, 2026

Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 - BioSpace

Apr 17, 2026

Apr 16, 2026

Press Release: Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 - Moomoo

Apr 16, 2026

Apr 13, 2026

Stock Recap: Whats the analyst consensus on Fulgent Genetics Inc2026 Growth vs Value & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Apr 13, 2026

Pullback Watch: Is Fulgent Genetics Inc a momentum stock2026 Levels & Daily Momentum Trading Reports - baoquankhu1.vn

Apr 13, 2026

Stop Loss: Can Fulgent Genetics Inc stock outperform in a bear market2026 Biggest Moves & Risk Managed Investment Entry Signals - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026